Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.90NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.169NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.53NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.513NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.338NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.284NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.9.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.498NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.184NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.187NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
D.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.110.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.214NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.284NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.351.3 (Beta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.318NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
R.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.29 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
ML.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.283NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.96NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.145NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.547NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.247NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.205NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.110NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.434NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.181NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.6.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.37NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.547ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.247ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.4.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.205ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.110ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.434ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.4.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.181ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.6.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.37ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.2.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
CQ.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
CH.1.1.24ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BA.5.2.43ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used